Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib with Temozolomide and Radiation for Newly Diagnosed Glioblastoma
NCT00274833Phase 2Completed
- Start
- Oct 2005
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in glioblastoma multiforme (GBM). Started Oct 2005; status: completed.
02
Drugs
erlotinib
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00274833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274833.